News / Business
ARYx Therapeutics Inc (NASDAQ:ARYX) to Release Q1 2008 Earnings May 13
ARYx
Therapeutics Inc (NASDAQ:ARYX) will release
the first quarter earnings for 2008 on Tuesday, May 12. The company will hold a conference call at
8:00 am PT that morning. The call will
be available for listening via webcast at investors.aryx.com/events.cfm.
ARYx
Therapeutics, Inc. (ARYx) is a biopharmaceutical company focused on developing
a portfolio of potentially safer oral product candidates that retain the
efficacy of commercially successful drugs for established chronic markets. The
Company employs its RetroMetabolic Drug Design technology to engineer
structurally molecules. The process utilizes a series of steps designed to
eliminate specific unwanted effects of the original drug.
ARYx's most
advanced product candidate is ATI-7505, which has successfully completed Phase
2 clinical trials for the treatment of gastroesophageal reflux disease and
symptoms associated with functional dyspepsia. Other potential products in
advanced stages of development are ATI-5923 for anticoagulation and ATI-2042
for atrial fibrillation. The Company has several other products in the
pipeline.
Find more Earnings events
on Finditt Events.
Read more
Business News at:
